25D-NBOMe (or
NBOMe-2C-D) is a derivative of the
phenethylamine derived hallucinogen
2C-D. It acts in a similar manner to related compounds such as
25I-NBOMe, which is a potent
agonist at the
5HT2A receptor. 25D-NBOMe has been sold as a street drug since 2010 and produces similar effects in humans to related compounds such as
25I-NBOMe and
25C-NBOMe. It was banned as a
Temporary Class Drug in the UK on 10 June 2013 after concerns about its recreational use.